SCHEMBL22481349

SCHEMBL22481349

O=c1[nH]c2cc(C(F)(F)F)c(/N=N/c3ccccc3)cc2n(CP(=O)(O)O)c1=O

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GRIA1 P42261 14/20 0.51
GRIA2 P42262 14/20 0.51
GRIA3 P42263 14/20 0.51
GRIA4 P48058 14/20 0.51
GRIN2D O15399 1/20 0.51
GRIN3B O60391 1/20 0.51
GRIN1 Q05586 1/20 0.51
GRIN2A Q12879 1/20 0.51
GRIN2B Q13224 1/20 0.51
GRIN2C Q14957 1/20 0.51
GRIN3A Q8TCU5 1/20 0.51
GRIK1 P39086 7/20 0.48
GRIK2 Q13002 7/20 0.48
GRIK3 Q13003 7/20 0.48
GRIK5 Q16478 7/20 0.48
GRIK4 Q16099 6/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8181851 0.82 GRIA1 (0.54) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL8095672 0.80 GRIA1 (0.51) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL8091804 0.78 GRIA1 (0.49) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL8340446 0.77 GRIA1 (0.50) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL8346010 0.74 GRIA1 (0.55) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL8083730 0.74 GRIA1 (0.52) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL7360391 0.73 GRIA1 (0.59) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL8098793 0.73 GRIA1 (0.53) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL8122798 0.73 GRIA1 (0.53) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL8107335 0.73 GRIA1 (0.53) GRIA1GRIA2GRIA3GRIA4GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200308539-A1 AFFINITY-TAGGED PHOTOSWITCHES AND METHODS OF USE THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2020-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200308539-A1 AFFINITY-TAGGED PHOTOSWITCHES AND METHODS OF USE THEREOF CD2BP2, AGBL2, CLTB GRIA1 1906/4885GRIA2 1689/4885GRIA3 1415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.